Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

Autor: González-Martín, Antonio, Chung, Hyun Cheol, Saada-Bouzid, Esma, Yanez, Eduardo, Senellart, Helene, Cassier, Philippe A., Basu, Bristi, Corr, Bradley R., Girda, Eugenia, Dutcus, Corina, Okpara, Chinyere E., Ghori, Razi, Jin, Fan, Groisberg, Roman, Lwin, Zarnie
Zdroj: In Gynecologic Oncology July 2024 186:182-190
Databáze: ScienceDirect
Externí odkaz: